<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mosley, Mary</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Steinberg, Jonathan S.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Botulinum Toxin Reduced AF Burden, Heart Rate Variability at 1 Year in Pilot Study</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-07-02 10:57:42</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">10-11</style></pages><abstract><style  face="normal" font="default" size="100%">Secondary analysis of a small pilot study has shown that botulinum toxin vs placebo reduces the burden of atrial fibrillation at 1 year after coronary artery bypass graft surgery. An improvement in heart rate variability also suggests that botulinum toxin injected into fat pads is a neuromodulator with effects on the autonomic nervous system.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>